Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/221595
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Papadimitriou, Nikos | - |
dc.contributor.author | Kazmi, Nabila | - |
dc.contributor.author | Tsilidis, Konstantinos K. | - |
dc.contributor.author | Richmond, Rebecca C. | - |
dc.contributor.author | Lynch, Brigid M. | - |
dc.contributor.author | Bendinelli, Benedetta | - |
dc.contributor.author | Ricceri, Fulvio | - |
dc.contributor.author | Sánchez Pérez, María José | - |
dc.contributor.author | Trobajo-sanmartin, Camino | - |
dc.contributor.author | Jakszyn, Paula | - |
dc.contributor.author | Simeon, Vittorio | - |
dc.contributor.author | Severi, Gianluca | - |
dc.contributor.author | Perduca, Vittorio | - |
dc.contributor.author | Truong, Thérèse | - |
dc.contributor.author | Ferrari, Pietro | - |
dc.contributor.author | Keski-Rahkonen, Pekka | - |
dc.contributor.author | Weiderpass, Elisabete | - |
dc.contributor.author | Eichelmann, Fabian | - |
dc.contributor.author | Schulze, Matthias B. | - |
dc.contributor.author | Katzke, Verena | - |
dc.contributor.author | Fortner, Renée T. | - |
dc.contributor.author | Heath, Alicia K. | - |
dc.contributor.author | Aune, Dagfinn | - |
dc.contributor.author | Harewood, Rhea | - |
dc.contributor.author | Dahm, Christina C. | - |
dc.contributor.author | Aginagalde Llorente, Adrian Hugo | - |
dc.contributor.author | Gunter, Marc J. | - |
dc.contributor.author | Murphy, Neil | - |
dc.contributor.author | Lewis, Sarah J. | - |
dc.date.accessioned | 2025-06-17T10:56:42Z | - |
dc.date.available | 2025-06-17T10:56:42Z | - |
dc.date.issued | 2025-01-30 | - |
dc.identifier.issn | 1538-7755 | - |
dc.identifier.uri | https://hdl.handle.net/2445/221595 | - |
dc.description.abstract | Background: Current evidence suggests higher physical activity (PA) levels are associated with a reduced risk of colorectal cancer. However, the mediating role of the circulating metabolome in this relationship remains unclear.Methods: Targeted metabolomics data from 6,055 participants in the European Prospective Investigation into Cancer and Nutrition cohort were used to identify metabolites associated with PA and derive a metabolomic signature of PA levels. PA levels were estimated using the validated Cambridge PA index based on baseline questionnaires. Mediation analyses were conducted in a nested case-control study (1,585 cases, 1,585 controls) to examine whether individual metabolites and the metabolomic signature mediated the PA-colorectal cancer association.Results: PA was inversely associated with colorectal cancer risk (OR per category change: 0.90, 95% confidence interval, 0.83-0.97; P value = 0.009). PA levels were associated with 24 circulating metabolites after FDR correction, with the strongest associations observed for phosphatidylcholine acyl-alkyl (PC ae) C34:3 (FDR-adjusted P value = 1.18 x 10-10) and lysophosphatidylcholine acyl C18:2 (FDR-adjusted P value = 1.35 x 10-6). PC ae C34:3 partially mediated the PA-colorectal cancer association (natural indirect effect: 0.991, 95% confidence interval, 0.982-0.999; P value = 0.04), explaining 7.4% of the association. No mediation effects were observed for the remaining metabolites or the overall PA metabolite signature.Conclusions: PC ae C34:3 mediates part of the PA-colorectal cancer inverse association, but further studies with improved PA measures and extended metabolomic panels are needed.Impact: These findings provide insights into PA-related biological mechanisms influencing colorectal cancer risk and suggest potential targets for cancer prevention interventions. | - |
dc.format.extent | 10 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | American Association for Cancer Research (AACR) | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1158/1055-9965.EPI-24-1390 | - |
dc.relation.ispartof | Cancer Epidemiology Biomarkers & Prevention, 2025, vol. 34, num. 4, p. 578-587 | - |
dc.relation.uri | https://doi.org/10.1158/1055-9965.EPI-24-1390 | - |
dc.rights | cc-by-nc-nd (c) Papadimitriou et al., 2025 | - |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
dc.subject.classification | Càncer colorectal | - |
dc.subject.classification | Metabolòmica | - |
dc.subject.other | Colorectal cancer | - |
dc.subject.other | Metabolomics | - |
dc.title | Identifying Metabolomic Mediators of the Physical Activity and Colorectal Cancer Relationship | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.date.updated | 2025-06-10T10:22:58Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 39883068 | - |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
epi-24-1390.pdf | 834.09 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License